Kartikeya Cherabuddi MD
HIV/AIDS Medicine, Infectious Disease, Clinical Informatics
Chief Hospital Epidemiology Officer, Tampa General Hospital Professor, Infectious Diseases, Univ of South Florida
Join to View Full Profile
1600 Sw Archer RdDivision Of Infectious Diseases, Department Of MedicineGainesville, FL 32610
Phone+1 352-265-5481
Dr. Cherabuddi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Kartik Cherabuddi provides clinical care to patients with complex infectious diseases; patients living with HIV; and internal medicine patients. He serves as a specialist for antibiotic resistant pathogen infections and is the Chief Hospital Epidemiology Officer at Tampa General Health System.
A Master Clinician Society inductee, Dr. Cherabuddi is a recognized Exemplary Clinician for multiple years for excellence in teaching. He enjoys teaching medical students, residents and ID fellows. He has been recognized as the Attending of the year by the residents.
Dr. Cherabuddi conducts research in antibiotic resistance, antimicrobial use, and genetic sequencing of microorganisms. He also collaborates with researchers on (re)emerging viral infections.
Dr. Cherabuddi serves on international infectious diseases committees to develop enhanced training in Antibiotic Stewardship. He has advised and volunteered with education efforts around the world, including in Asia (India, Nepal) and Africa (Democratic Republic of Congo).
Education & Training
University of FloridaFellowship, Infectious Disease, 2011 - 2013
Ascension Illinois/Saint FrancisResidency, Internal Medicine, 2007 - 2011
Kakatiya Medical College NTRClass of 2004
Certifications & Licensure
FL State Medical License 2013 - 2027
IL State Medical License 2007 - 2011
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Clinical Trials
- A Study of SARS CoV-2 Infection and Potential Transmission in Individuals Immunized With Moderna COVID-19 Vaccine Start of enrollment: 2021 Mar 24
- Efficacy and Safety of Molnupiravir (MK-4482) in Hospitalized Adult Participants With COVID-19 (MK-4482-001) Start of enrollment: 2020 Oct 19
- DOTS: Dalbavancin as an Option for Treatment of Staphylococcus Aureus Bacteremia Start of enrollment: 2021 Apr 22
- Join now to see all
Publications & Presentations
PubMed
- Development and implementation of learning collaboratives for infection prevention and control education in long-term care facilities.Cindy Prins, Mishal Khan, Nicole M Marlow, Avery Bollinger, Cassandra L Johnson
American Journal of Infection Control. 2025-02-01 - Infection prevention and control in long-term care facilities in Florida: A needs assessment survey.Cindy Prins, Avery E Bollinger, Cassandra L Johnson, Jamie L Pomeranz, Sally M Bethart
American Journal of Infection Control. 2025-02-01 - 4 citationsBrincidofovir for disease progression due to suspected tecovirimat resistance in association with advanced HIV.Iris Harrison, Kathryn DeSear, Barbara A Santevecchi, Veena Venugopalan, Kartikeya Cherabuddi
International Journal of STD & AIDS. 2024-07-01
Press Mentions
UF leprosy symposium addresses increase in Florida casesOctober 28th, 2023
A new antifungal drug for candidaemiaJune 15th, 2023- 2023 NIAMRRE Annual Conference Addressing the Gaps in AMRMay 16th, 2023
- Join now to see all
External Links
- Scholar profilehttps://scholar.google.co.in/citations?user=OiXdBc8AAAAJ&hl=en
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
